Neurogene Inc.
NGNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,953 | -$22,016 | -$22,647 | -$19,514 |
| Dep. & Amort. | $812 | $767 | $762 | $798 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,408 | $4,048 | $2,487 |
| Change in WC | -$1,279 | -$401 | -$1,414 | -$896 |
| Other Non-Cash | $1,737 | -$1,220 | -$1,523 | -$371 |
| Operating Cash Flow | -$19,683 | -$19,462 | -$20,774 | -$17,496 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$126 | -$148 | -$780 | -$116 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$78,107 | -$60,402 | -$88,965 | -$118,250 |
| Inv. Sales/Matur. | $100,672 | $68,000 | $44,700 | $15,750 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $22,439 | $7,450 | -$45,045 | -$102,616 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13 | -$14 | -$15 | -$13 |
| Stock Issued | $9,871 | $70 | $0 | $186,187 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$2 | $19 | $3,891 |
| Financing Cash Flow | $9,858 | $54 | $4 | $190,065 |
| Forex Effect | -$422 | $0 | $0 | $0 |
| Net Chg. in Cash | $12,192 | -$11,958 | -$65,815 | $69,953 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $58,813 | $71,110 | $136,925 | $66,972 |
| End Cash | $71,005 | $59,152 | $71,110 | $136,925 |
| Free Cash Flow | -$19,809 | -$19,610 | -$21,554 | -$17,612 |